St John's wort modulation and developmental expression of multidrug transporters in the rat

Phytotherapy Research

Volumn 20, Issue 6, 2006, Pages 468-473

  Garrovo, Chiara ^a   Rosati, Anna ^a   Bartoli, Fiora ^a   Decorti, Giuliana ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Cytochrome CYP3A2; Induction; Multidrug resistance related proteins; P glycoprotein; St John's wort

Indexed keywords

CYTOCHROME P450 3A2; GLYCOPROTEIN P; HYPERICUM PERFORATUM EXTRACT; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST FEEDING; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENE SEQUENCE; HYPERICUM PERFORATUM; NONHUMAN; NUCLEOTIDE SEQUENCE; ONTOGENY; PROTEIN EXPRESSION; RAT;

ANIMALS; CYTOCHROME P-450 CYP3A; FEMALE; FETAL DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HYPERICUM; KIDNEY; LIVER; P-GLYCOPROTEINS; PLANT EXTRACTS; PREGNANCY; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

HYPERICUM PERFORATUM; RATTUS NORVEGICUS;

EID: 33745475769     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.1880     Document Type: Article

References (40)

1. Bates SE, Zhan ZR, Regis J, Gamelin E. 1999. Measuring MDR-1 by quantitative RT-PCR. In Cytotoxic Drug Resistance Mechanisms, Brown R, Boger Brown U (eds). Humana Press Inc: Totowa; 63-81.
2. Bilia AR, Gallori S, Vincieri FF. 2002. St John's wort and depression - efficacy, safety and tolerability - an update. Life Sci 70: 3077-3096.
3. Cada AM, Hansen DK, LaBorde JB, Ferguson SA. 2001. Minimal effects from developmental exposure to St John's wort (Hypericum perforatum) in Sprague-Dawley rats. Nutr Neurosci 4: 135-141.
4. Chan LY, Chiu PY, Lau TK. 2001. A study of hypericin-induced teratogenicity during organogenesis using a whole rat embryo culture model. Fertil Steril 76: 1073-1074.
5. Conseil G, Baubichon Cortay H, Dayan G, Jault JM, Barron D, Di Pietro A. 1998. Flavonoids: A class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein. Proc Natl Acad Sci USA 95: 9831-9836.
6. Dresser GK, Schwarz UI, Wilkinson GR, Kim RB. 2003. Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects. Clin Pharmacol Ther 73: 41-50.
7. Durr D, Stieger B, Kullak-Ublick GA et al. 2000. St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin Pharmacol Ther 68: 598-604.
8. Dutt A, Priebe TS, Teeter LD, Kuo MT, Nelson JA. 1992. Postnatal development of organic cation transport and mdr gene expression in mouse kidney. J Pharmacol Exp Ther 261: 1222-1230.
9. Ernst E, Rand JI, Barnes J, Stevinson C. 1998. Adverse effects profile of the herbal antidepressant St John's wort (Hypericum perforatum L.). Eur J Clin Pharmacol 54: 589-594.
10. Fugh-Berman A. 2000. Herb-drug interactions. Lancet 355: 134-138.
11. Gottesman MM, Ambudkar SV. 2001. Overview: ABC transporters and human disease. J Bioenerg Biomembr 33: 453-458.
12. Gregoretti B, Stebel M, Candussio L, Crivellato E, Bartoli F, Decorti G. 2004. Toxicity of Hypericum perforatum (St John's wort) administered during pregnancy and lactation in rats. Toxicol Appl Pharmacol 200: 201-205.
13. Hennessy M, Kelleher D, Spiers JP et al. 2002. St John's Wort increases expression of P-glycoprotein: Implications for drug interactions. Br J Clin Pharmacol 53: 75-82.
14. Johne A, Brockmoller J, Bauer S, Maurer A, Langheinrich M, Roots I. 1999. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clin Pharmacol Ther 66: 338-345.
15. Johne A, Schmider J, Brockmoller J et al. 2002. Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St John's Wort (Hypericum perforatum). J Clin Psychopharmacol 22: 46-54.
16. Leazer TM, Klaassen CD. 2003. The presence of xenobiotic transporters in rat placenta. Drug Metab Disp 31: 153-167.
17. Leslie EM, Deeley RG, Cole SPC. 2003. Bioflavonoid stimulation of glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). Drug Metab Disp 31: 11-15.
18. Leslie EM, Mao Q, Oleschuk CJ, Deeley RG, Cole SP. 2001. Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and ATPase activities by interaction with dietary flavonoids. Mol Pharmacol 59: 1171-1180.
19. Mahmood B, Daood MJ, Hart C, Hansen TW, Watchko JF. 2001. Ontogeny of P-glycoprotein in mouse intestine, liver, and kidney. J Investig Med 49: 250-257.
20. Mai I, Kruger H, Budde K et al. 2000. Hazardous pharmacokinetic interaction of Saint John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin. Int J Clin Pharm Ther 38: 500-502.
21. Mannel M. 2004. Drug interactions with St John's wort: mechanisms and clinical implications. Drug Saf 27: 773-797.
22. Mathijssen RHJ, Verweij J, deBruijn P, Loos WJ, Sparreboom A. 2002. Effects of St John's wort on irinotecan metabolism. J Natl Cancer Inst 94: 1247-1249.
23. Matsuoka Y, Okazaki M, Kitamura Y, Taniguchi T. 1999. Developmental expression of P-glycoprotein (Multidrug resistance gene product) in the rat brain. J Neurobiol 39: 383-392.
24. Moore LB, Goodwin B, Jones SA et al. 2000. St John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 97: 7500-7502.
25. Mottino AD, Hoffman T, Jennes L, Cao J, Vore M. 2001. Expression of multidrug resistance-associated protein 2 in small intestine from pregnant and postpartum rats. Am J Physiol Gastrointest Liver Physiol 280: G1261-G1273.
26. Nebel A, Schneider BJ, Baker RK, Kroll DJ. 1999. Potential metabolic interaction between St John's wort and theophylline. Ann Pharmacother 33: 502.
27. Perloff MD, von Moltke LL, Stormer E, Shader RI, Greenblatt DJ. 2001. Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure. Br J Pharmacol 134: 1601-1608.
28. Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J. 2000. Indinavir concentrations and St John's wort. Lancet 355: 547-548.
29. Rayburn WF, Christensen HD, Gonzalez CL. 2000. Effect of antenatal exposure to Saint John's wort (Hypericum) on neurobehavior of developing mice. Am J Obstet Gynecol 183: 1225-1231.
30. Rayburn WF, Gonzalez CL, Christensen HD, Harkins TL, Kupiec TC. 2001a. Impact of hypericum (St-John's-wort) given prenatally on cognition of mice offspring. Neurotoxicol Teratol 23: 629-637.
31. Rayburn WF, Gonzalez CL, Christensen HD, Stewart JD. 2001b. Effect of prenatally administered hypericum (St John's wort) on growth and physical maturation of mouse offspring. Am J Obstet Gynecol 184: 191-195.
32. Roby CA, Anderson GD, Kantor E, Dryer DA, Burstein AH. 2000. St John's Wort: Effect on CYP3A4 activity. Clin Pharmacol Ther 67: 451-457.
33. Rosati A, Maniori S, Decorti G, Candussio L, Giraldi T, Bartoli F. 2003. Physiological regulation of P-glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny. Dev Growth Differ 45: 377-387.
34. Schiengold M, Schwantes L, Schwartsmann G, Chies JA, Nardi NB. 2001. Multidrug resistance gene expression during the murine ontogeny. Mech Ageing Dev 122: 255-270.
35. Shibayama Y, Ikeda R, Motoya T, Yamada K. 2004. St John's Wort (Hypericum perforatum) induces overexpression of multidrug resistance protein 2 (MRP2) in rats: a 30-day ingestion study. Food Chem Toxicol 42: 995-1002.
36. Stevinson C, Ernst E. 1999. Hypericum for depression. An update of the clinical evidence. Eur Neuropsycopharmacol 9: 501-505.
37. Szegedi A, Kohnen R, Dienel A, Kieser M. 2005. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine. Br Med J 330: 503-507.
38. Troutman MD, Thakker DR, Carson SW, Hill-Zabala CE. 2000. Activation and inhibition of P-glycoprotein (P-gp) mediated efflux of digoxin by St John's Wort Extract. AAPS Pharm Sci 2: 948.
39. Wang ZQ, Hamman MA, Huang SM, Lesko LJ, Hall SD. 2002. Effect of St John's wort on the pharmacokinetics of fexofenadine. Clin Pharmacol Ther 71: 414-420.
40. Zinchuk VS, Okada T, Akimaru K, Seguchi H. 2002. Asynchronous expression and colocalization of Bsep and Mrp2 during development of rat liver. Am J Physiol Gastrointest Liver Physiol 282: G540-G548.